Maximizing Success: A Professional, Educated, and Profit-Focused Approach to Blogging for Readers – AccessWire Article
Levi & Korsinsky Investigates Potential Securities Violations by Syros Pharmaceuticals The Investigation On August 18, 2024, Levi & Korsinsky announced that it has launched an investigation into Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) for possible violations of federal securities laws. This investigation comes on the heels of a press release issued by Syros on August 12, 2024,…